12-Month Lobbying Summary - In-house Corporation

• Subject matter details in previous versions

  Details Regarding the Identified Subject Matter

  Subject matters	Details	Categories
  Subject matters were not required to be associated with subject matter details when this content was submitted	Le développement d'un outil d'aide dans la gestion des données dans la lutte à la Résistance antimicrobienne (RAM). Et sa promotion à l'international	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Soutien financier dans le développement des connectivités entre les appareils diagnostics et l'application. Support à l'exportation et à la commercialisation	Grant, Contribution or Other Financial Benefit

  Subject matters in previous versions

  • Health
  • Industry
  • International Development
  • Science and Technology

Government Institutions

• Innovation, Science and Economic Development Canada (ISED)
• Public Health Agency of Canada (PHAC)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

• Oral communication
• Written communication

Senior Officers whose lobbying activities represent less than 20% of their Duties

• Colin Hill, GM & Head of Clinical Operations North America | No public offices held
• Stéphanie Bonneau, Industry Sales Manager | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

• Sophie Canobio, Marketing Director | No public offices held
• Frédéric Dubé, Government Affairs & Market Access Director | No public offices held

• Lobbyists in previous versions

  Senior Officers whose lobbying activities represent less than 20% of their Duties

  • Julie Emond, Vice-Présidente & Directrice Générale | No public offices held